Bio-Pharm Solutions
Bio-Pharm Solutions is a new drug developer specializing in the central nervous system and rare diseases.
Industries
biopharma
clinical-trials
pharmaceutical
Nr. of Employees
small (1-50)
Bio-Pharm Solutions
Patents
Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease
US-11931332-B2
View DetailsSulfamate derivative compounds for use in treating or alleviating a psychiatric disorder
US-11896593-B2
View DetailsCarbamate derivative compounds, processes for preparing them and their uses
US-11168052-B2
View DetailsPhenyl carbamate compound and a composition for neuroprotection comprising the same
US-10525030-B2
View DetailsSulfamate derivative compounds, processes for preparing them and their uses
US-10351519-B2
View Details
Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease
US-11931332-B2
View DetailsSulfamate derivative compounds for use in treating or alleviating a psychiatric disorder
US-11896593-B2
View DetailsCarbamate derivative compounds, processes for preparing them and their uses
US-11168052-B2
View DetailsPhenyl carbamate compound and a composition for neuroprotection comprising the same
US-10525030-B2
View DetailsSulfamate derivative compounds, processes for preparing them and their uses
US-10351519-B2
View DetailsProducts
JBPOS0101
A candidate compound for treating infantile spasms and partial onset seizures, currently in clinical trials for various CNS conditions.
ADD422007
A drug candidate with phase 1 IND approval for diabetic neuropathic pain, focusing on CNS-related conditions.
ADD485002
A drug candidate targeting Parkinson's Disease, part of Bio-Pharm Solutions' CNS-focused pipeline.
JBPOS0101
A candidate compound for treating infantile spasms and partial onset seizures, currently in clinical trials for various CNS conditions.
ADD422007
A drug candidate with phase 1 IND approval for diabetic neuropathic pain, focusing on CNS-related conditions.
ADD485002
A drug candidate targeting Parkinson's Disease, part of Bio-Pharm Solutions' CNS-focused pipeline.